📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Motilal Oswal Declares Interim Dividend of Rs 6 Per Share; Sets Record Date for Jan 31, 2026
Motilal Oswal Financial Services Limited has declared an interim dividend of Rs 6 per equity share for the Financial Year 2025-26. This dividend is calculated on a face value of Re 1 per share, representing a 600% payout. The company has fixed January 31, 2026, as the record date to identify eligible shareholders. The dividend distribution is expected to be completed by February 25, 2026, providing a timely cash return to investors.
Key Highlights
Interim dividend of Rs 6 per equity share declared for FY 2025-26
Dividend payout is based on a face value of Re 1 per share
Record date for determining shareholder eligibility is January 31, 2026
Payment of the interim dividend will be completed on or before February 25, 2026
💼 Action for Investors
Investors seeking dividend income should ensure they hold the stock before the ex-dividend date to qualify for the Rs 6 per share payout. The declaration reflects the company's strong profitability and commitment to shareholder returns.
Motilal Oswal Q3 FY26 Revenue Grows 17% YoY to ₹2,008 Cr; PAT Steady at ₹569 Cr
Motilal Oswal Financial Services reported a 17.4% year-on-year growth in consolidated revenue from operations, reaching ₹2,008.5 crore for the quarter ended December 31, 2025. While Profit After Tax (PAT) remained flat at ₹569.16 crore compared to the previous year, the Total Comprehensive Income saw a significant jump to ₹725.04 crore, driven by fair value gains. For the nine-month period, the company has achieved a substantial PAT of ₹2,508.18 crore. Additionally, the firm strengthened its capital position by raising ₹300 crore through the private placement of Non-Convertible Debentures (NCDs).
Key Highlights
Consolidated Revenue from operations increased 17.4% YoY to ₹2,008.5 crore in Q3 FY26.
Profit After Tax (PAT) for the quarter stood at ₹569.16 crore, maintaining stability YoY.
Total Comprehensive Income surged to ₹725.04 crore from ₹460.86 crore in the same quarter last year.
Raised ₹300 crore through Private Placement of NCDs during the quarter for business operations.
Nine-month EPS (Basic) reached a strong ₹41.83 per share.
💼 Action for Investors
Investors should note the strong top-line growth and the significant boost in comprehensive income, which reflects well on the company's investment portfolio. The steady PAT despite rising revenues suggests a focus on scale, making it a solid hold for long-term exposure to the Indian capital markets.
Motilal Oswal Q3 FY26 Net Profit Rises 14% to ₹689 Cr; Declares ₹6 Interim Dividend
Motilal Oswal Financial Services reported a strong performance for Q3 FY26, with consolidated net profit growing 14% year-on-year to ₹689 crore. The Board has declared an interim dividend of ₹6 per share, reflecting healthy cash flows and commitment to shareholder returns. Total revenue from operations for the quarter stood at ₹2,065 crore, a significant jump from ₹1,720 crore in the same period last year. The company also successfully raised ₹300 crore via Non-Convertible Debentures (NCDs) during the quarter to support its business objectives.
Key Highlights
Consolidated Net Profit for Q3 FY26 increased to ₹689 crore from ₹605 crore in Q3 FY25.
Total Revenue from operations grew by 20% YoY to ₹2,065 crore.
Declared an interim dividend of ₹6 per equity share on a face value of ₹1 each.
Successfully raised ₹300 crore through private placement of Non-Convertible Debentures (NCDs).
Basic Earnings Per Share (EPS) for the quarter improved to ₹11.31 from ₹10.12 YoY.
💼 Action for Investors
Investors should find the consistent growth in both top-line and bottom-line encouraging, alongside the healthy dividend payout. The stock remains a strong proxy for the Indian capital markets and wealth management sector.
Motilal Oswal Q3FY26 Operating PAT up 16% YoY to ₹611 Cr; Declares ₹6 Dividend
Motilal Oswal Financial Services reported its highest-ever quarterly operating PAT of ₹611 crore for Q3FY26, marking a 16% YoY growth. The Asset and Private Wealth Management segments were major drivers, contributing approximately 50% of the group's operating profit. Total Assets Under Advice (AUA) crossed the ₹7 lakh crore milestone, while the Treasury book grew to ₹9,562 crore with an 18.5% XIRR since inception. The company also declared an interim dividend of ₹6 per share, maintaining its consistent shareholder payout policy.
Key Highlights
Operating PAT grew 16% YoY to ₹611 Cr; Asset Management PAT surged 65% YoY to ₹227 Cr.
Total Assets Under Advice (AUA) crossed ₹7 lakh Cr; Mutual Fund AUM grew 40% YoY.
Treasury book reached ₹9,562 Cr with a healthy 18.5% XIRR since inception.
Net worth increased to ₹13,632 Cr, representing a 24% CAGR over the last decade.
Declared an interim dividend of ₹6 per equity share for the financial year.
💼 Action for Investors
The significant shift towards high-margin, fee-based recurring revenue (74% of total) improves earnings stability and justifies a positive outlook. Investors should note the strong 26% ROE and the company's proven ability to compound net worth without external capital raises.
Motilal Oswal Q3 FY26 Operating PAT Rises 16% YoY to ₹611 Cr; Declares ₹6 Dividend
Motilal Oswal Financial Services (MOFSL) reported a strong Q3 FY26 with consolidated operating PAT growing 16% YoY to ₹611 Cr, driven by a 65% surge in Asset Management profits. The company's total Assets Under Advice (AUA) crossed the ₹7 lakh Cr mark, reflecting a 17% YoY growth. Net worth reached ₹13,632 Cr as of December 2025, supported by a healthy annualized ROE of 26%. The board has also declared an interim dividend of ₹6 per equity share, continuing its trend of consistent capital return to shareholders.
Key Highlights
Consolidated Operating PAT grew 16% YoY to ₹611 Cr, with Asset & Private Wealth Management contributing ~50% of group profits.
Asset Management PAT surged 65% YoY to ₹227 Cr, driven by a 40% growth in Mutual Fund AUM and 62% growth in Private Alternates.
Total Assets Under Advice (AUA) reached ₹7+ lakh Cr, while the Treasury book grew to ₹9,562 Cr with an 18.5% XIRR since inception.
Share of fee-based and NII revenue increased to 74% of total operating net revenue, up from 58% in FY21.
Housing Finance segment showed recovery with AUM growing 24% YoY to ₹5,379 Cr and PAT rising 12% YoY to ₹42 Cr.
💼 Action for Investors
Investors should take note of the structural shift towards high-margin fee-based revenue and the strong compounding of the treasury book. The stock remains a robust proxy for India's capital market growth, backed by a 20% average dividend payout and strong ROE.
Motilal Oswal Reports ₹569 Cr Q3 Profit; Declares ₹6 Interim Dividend
Motilal Oswal Financial Services (MOTILALOFS) reported a consolidated net profit of ₹569.16 crore for Q3 FY26, showing steady performance compared to ₹560.05 crore in the previous year. The company's total revenue from operations grew by approximately 11.9% year-on-year to ₹2,011.13 crore. A key highlight for shareholders is the declaration of an interim dividend of ₹6 per share (600% of face value). Additionally, the company successfully raised ₹300 crore through Non-Convertible Debentures (NCDs) during the quarter to bolster its capital position.
Key Highlights
Declared an interim dividend of ₹6 per equity share of face value ₹1 each for FY 2025-26.
Consolidated revenue from operations rose to ₹2,011.13 crore in Q3 FY26 from ₹1,797.36 crore in Q3 FY25.
Consolidated Net Profit for the quarter stood at ₹569.16 crore with a basic EPS of ₹9.42.
Raised ₹300 crore through Private Placement of Non-Convertible Debentures (NCDs) during the quarter.
Nine-month (9M FY26) consolidated net profit reached ₹2,100.61 crore.
💼 Action for Investors
Investors should view the ₹6 interim dividend and steady revenue growth as signs of strong operational health. The stock remains a solid play in the diversified financial services sector with consistent shareholder payouts.
BLAL Reports Nil Revenue and Net Loss of ₹46.04 Lakhs for Q3 FY26
BEML Land Assets Limited (BLAL) reported zero revenue from operations for the quarter ended December 31, 2025, reflecting its nature as a holding company for non-core assets. The company posted a net loss of ₹46.04 lakhs for the quarter, compared to a loss of ₹44.03 lakhs in the corresponding quarter of the previous year. For the nine-month period ended December 2025, the net loss widened to ₹373.68 lakhs from ₹332.88 lakhs year-on-year. Additionally, the company noted a regulatory non-compliance regarding the insufficient number of independent directors on its board.
Key Highlights
Revenue from operations and total income remained at zero for the quarter ended December 31, 2025.
Net loss for Q3 FY26 stood at ₹46.04 lakhs versus a loss of ₹44.03 lakhs in Q3 FY25.
Total expenses for the nine-month period increased to ₹373.68 lakhs from ₹332.88 lakhs in the previous year.
Negative reserves widened to ₹4,426.97 lakhs as of December 31, 2025, compared to ₹4,011.43 lakhs a year ago.
The company is currently non-compliant with SEBI Listing Regulations regarding the required number of Independent Directors.
💼 Action for Investors
As BLAL is a demerged entity holding surplus land assets, investors should focus on land monetization progress rather than quarterly earnings. The current lack of revenue and widening losses make the stock a speculative play on asset valuation.
Dr. Lal PathLabs Launches SOVAAKA Wellness Centre to Expand into Premium Preventive Care
Dr. Lal PathLabs has launched SOVAAKA, a premium wellness center in Gurugram, marking its entry into the high-growth preventive healthcare segment. The facility integrates advanced diagnostics like 1.5T MRI and genetic testing with AI-driven insights to offer personalized health programs. This strategic move aims to transition the company from disease detection to predictive wellness, targeting higher-margin lifestyle disease management. As of March 2025, the company operates 298 labs and over 6,607 service centers, providing a strong foundation for scaling such premium initiatives.
Key Highlights
Launched SOVAAKA in Gurugram, a next-generation wellness center blending science and AI technology.
Equipped with high-end diagnostic tools including 1.5T MRI, low-dose CT, and DEXA scanning.
Offers specialized, doctor-designed programs like Eterna for women and Vita for men.
Strategic focus on the growing preventive health market to address rising Non-Communicable Diseases.
Company network includes 298 clinical labs and 12,365 pick-up points as of March 31, 2025.
💼 Action for Investors
This expansion into premium wellness is a positive move to increase average revenue per patient; investors should watch for further rollouts of this format in other metros.
Motilal Oswal Shareholders Approve New Director Appointments with Over 99% Majority
Motilal Oswal Financial Services Limited (MOTILALOFS) has announced the successful passage of six key resolutions via postal ballot as of December 30, 2025. Shareholders approved the appointment and remuneration of Mr. Pratik Oswal and Mr. Vaibhav Agrawal as Non-Executive Directors. Additionally, two new Independent Directors, Mr. Joseph Conrad Agnelo D’Souza and Mr. Ashok Kumar Parasmal Kothari, were appointed to the board. All resolutions received overwhelming support, with most passing with over 99% of the votes in favor.
Key Highlights
Appointment of Mr. Pratik Oswal as Non-Executive Director approved with 99.54% votes in favor.
Appointment of Mr. Vaibhav Agrawal as Non-Executive Director approved with 99.33% votes in favor.
Remuneration approvals for both Pratik Oswal and Vaibhav Agrawal received over 99.8% support from voting shareholders.
Two new Independent Directors were appointed via special resolutions to strengthen board governance.
A total of 2,41,544 shareholders were eligible for voting as of the November 21, 2025 cut-off date.
💼 Action for Investors
These appointments represent a planned evolution of the company's leadership and governance; investors should view this as a routine strengthening of the board and no immediate action is required.
SCILAL Extends Capt. B. K. Tyagi's Additional Charge as CMD for 6 Months
The Ministry of Ports, Shipping and Waterways has approved the extension of Capt. B. K. Tyagi's additional charge as Chairman and Managing Director (CMD) of SCILAL. The extension is effective for a six-month period from January 1, 2026, to June 30, 2026, or until further orders. Capt. Tyagi, who is also the CMD of Shipping Corporation of India (SCI), brings over 35 years of industry experience to the role. This move ensures leadership continuity for the company, which manages the non-core land and assets demerged from SCI.
Key Highlights
Extension of Capt. B. K. Tyagi's additional charge as CMD for a 6-month period.
New term effective from January 1, 2026, through June 30, 2026.
Capt. Tyagi concurrently serves as CMD of Shipping Corporation of India (SCI).
Appointment is subject to final approval from the Appointments Committee of the Cabinet (ACC).
Capt. Tyagi has over 35 years of experience in shipping, navigation, and general management.
💼 Action for Investors
This is a routine administrative extension ensuring leadership stability. Investors should monitor for any future announcements regarding a permanent CMD appointment for the demerged entity.
Dr. Lal Path Labs Allots 8.37 Crore Bonus Shares in 1:1 Ratio
Dr. Lal Path Labs has completed the allotment of 8,37,75,510 bonus equity shares to eligible shareholders following its 1:1 bonus issue. The allotment was approved via a circular resolution on December 22, 2025, for shareholders on record as of December 19, 2025. This move doubles the company's total number of outstanding shares to 16,75,51,020. The paid-up equity share capital now stands increased at INR 167.55 crore, with the new shares ranking pari-passu with existing ones.
Key Highlights
Allotment of 8,37,75,510 fully paid-up bonus equity shares of face value INR 10 each.
Bonus issue executed in a 1:1 ratio for shareholders as of the December 19, 2025 record date.
Total paid-up equity capital increased from INR 83.77 crore to INR 167.55 crore.
Total number of equity shares outstanding increased to 16,75,51,020 shares.
New bonus shares rank pari-passu in all respects with existing equity shares.
💼 Action for Investors
Investors should note that while the number of shares in their portfolio has doubled, the stock price has been adjusted proportionally. No further action is required as the allotment is automatic for eligible shareholders.
MOTILALOFS Allots 30,000 NCDs aggregating to ₹300 Crore
Motilal Oswal Financial Services Limited has announced the allotment of 30,000 fully paid, secured, rated, redeemable, listed, senior Non-Convertible Debentures (NCDs). The face value of each NCD is ₹1,00,000, aggregating to a total issue size of ₹300 Crore. These NCDs are proposed to be listed on the National Stock Exchange of India Limited (NSE). The tenure of the instrument is 3 years, maturing on December 12, 2028, with coupon payments annually.
Key Highlights
Allotted 30,000 Secured NCDs
Each NCD has a face value of ₹1,00,000
Total issue size aggregates to ₹300 Crore
NCDs mature on December 12, 2028
Coupon payments are scheduled annually
💼 Action for Investors
Investors should review the terms of the NCDs, including the coupon rate and security details, as outlined in the General Information Document (GID) and Key Information Document (KID). Monitor the company's ability to maintain a minimum security cover of 1.00 times the outstanding principal amounts of the NCDs.
Dr. Lal PathLabs Increases Authorized Share Capital to INR 200 Crore
Dr. Lal PathLabs has received shareholder approval via postal ballot to significantly increase its authorized share capital. The limit has been raised from INR 107.96 crore to INR 200 crore, effectively doubling the company's capacity to issue new equity. This change involves a formal amendment to Clause V of the Memorandum of Association. While this is a regulatory enabling provision, it often serves as a precursor to future corporate actions such as bonus issues, rights issues, or equity-based fundraising.
Key Highlights
Authorized share capital increased from INR 107.96 crore to INR 200 crore.
Shareholder approval was obtained through a postal ballot concluded on December 07, 2025.
The new capital structure consists of 20,00,00,000 equity shares with a face value of INR 10 each.
Amendment to Clause V of the Memorandum of Association (MOA) has been officially implemented.
💼 Action for Investors
Investors should monitor the company for upcoming announcements regarding bonus issues or capital raises, as this move creates the necessary legal headroom for such actions.
Dr. Lal PathLabs Shareholders Approve Bonus Issue and New 2025 Employee Stock Unit Plan
Dr. Lal PathLabs has announced the successful passage of seven resolutions via postal ballot, most notably the issuance of bonus equity shares and an increase in authorized share capital. The 'Employee Restricted Stock Unit Plan 2025' was approved with 79.81% favor, although it faced significant institutional dissent with 51.5% of institutional votes cast against it. Additionally, shareholders cleared the path for secondary share acquisitions through a trust and a reduction in the 2022 options reserve. These approvals facilitate the company's capital restructuring and long-term incentive programs.
Key Highlights
Bonus Equity Shares issuance approved with 98.04% of total votes in favor.
Increase in Authorized Share Capital passed with a near-unanimous 99.84% majority.
New 'Employee Restricted Stock Unit Plan 2025' secured 79.81% support despite 51.5% institutional pushback.
Secondary acquisition of shares through a Trust route for ESOP implementation approved by 83.76% of voters.
Reduction of Options Reserve under the 2022 ESOP plan approved with 86.80% majority.
💼 Action for Investors
Investors should view the bonus issue as a positive move for share liquidity, though the high institutional dissent on the new ESOP plan suggests a need to monitor future management compensation and dilution.
Motilal Oswal to Raise Rs 300 Crore via Private Placement of NCDs
Motilal Oswal Financial Services' Finance Committee has approved the issuance of up to 30,000 Non-Convertible Debentures (NCDs) to raise Rs 300 crore. These NCDs are secured, rated, and will be issued on a private placement basis with a face value of Rs 1,00,000 each. The tenure for these senior bonds is set at 3 years, and they will be listed on the National Stock Exchange. This move is aimed at strengthening the company's capital position for its ongoing business operations.
Key Highlights
Issuance of up to 30,000 secured NCDs with a face value of Rs 1,00,000 each.
Total fundraise amount aggregates up to Rs 300 crore via private placement.
The NCDs have a fixed tenure of 3 years and will be listed on the NSE.
Security cover of 1.00x maintained through hypothecation of company receivables.
💼 Action for Investors
This is a routine capital-raising activity for a financial services firm; investors should track the cost of debt and its impact on overall margins.